Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00407134
First received: November 30, 2006
Last updated: December 19, 2007
Last verified: December 2007
  Purpose

Subjects with peritoneal dialysis are randomized to different groups. The different groups receive different intra-abdominal volumes and different glucose-concentrations.

The effects on blood pressure and other cardiovascular parameters (e.g. central blood pressure, augmentation index, ...) will be evaluated.


Condition Intervention
Peritoneal Dialysis
Procedure: Different abdominal volumes and different glucose-concentrations during peritoneal dialysis

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Blood pressure

Estimated Enrollment: 20
Study Start Date: December 2006
Study Completion Date: April 2007
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects with peritoneal dialysis
  • Aged 18-80 years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00407134

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Wim Van Biesen, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00407134     History of Changes
Other Study ID Numbers: 2006/382
Study First Received: November 30, 2006
Last Updated: December 19, 2007
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on April 17, 2014